TABLE 7

Percentage metabolism of Type I and Type II pyrethroids by rat P450 isoforms


Isoform

Bifenthrin

S-Bioallethrin

Bioresmethrin

β-Cyfluthrin

λ-Cyhalothrin

Cypermethrin

cis-Permethrin

trans-Permethrin

Resmethrin
CYP1A1 38.7 ± 3.1a 25.7 ± 1.5 66.3 ± 3.1 61.3 ± 0.6 64.7 ± 3.5 68.3 ± 1.2 47 ± 8 58.3 ± 7.5 81 ± 1.7
CYP1A2 8.7 ± 2.5 N.S. 31.3 ± 5.1 N.S. N.S. 12 ± 2.6 12.3 ± 4.5 38.3 ± 7.5 29 ± 11.5
CYP2A1 N.S.b 11.3 ± 3.5 N.S. 15.3 ± 3.5 N.S. 22.6 ± 2.5 N.S. N.S. 20.3 ± 2.9
CYP2B1 14.3 ± 4.7 N.S. N.S. N.S. N.S. 13 ± 2.6 N.S. N.S. N.S.
CYP2C6 88.7 ± 2.1 95 ± 1 97.7 ± 2.3 50 ± 2.6 39 ± 2.6 55.7 ± 2.9 83.7 ± 5 88.7 ± 2.1 91 ± 1.7
CYP2C11 68.7 ± 5.8 97.3 ± 0.6 94.3 ± 2.5 N.S. 58.3 ± 7.5 79.7 ± 4.2 77.7 ± 15.9 82 ± 5.3 89.3 ± 0.6
CYP2C12 12.7 ± 3.2 N.S. N.S. 14.7 ± 1.5 N.S. N.S. N.S. N.S. N.S.
CYP2C13 N.S. N.S. N.S. N.S. N.S. N.S. N.S. N.S. 12.7 ± 0.6
CYP2D1 N.S. N.S. N.S. 15.7 ± 5.1 42.3 ± 1.5 12.3 ± 4.6 N.S. N.S. N.S.
CYP2D2 N.S. N.S. 4 ± 1 N.S. N.S. 11 ± 4.4 N.S. N.S. 11 ± 2
CYP3A1 40.7 ± 8.3 81.7 ± 0.6 45 ± 7 46.3 ± 10.4 70.7 ± 5.9 59.7 ± 9.3 30.3 ± 5.5 N.S. 51.3 ± 1.5
CYP3A2
30.3 ± 4.5
56.3 ± 3.8
33 ± 9
24.3 ± 2.5
38.3 ± 3.5
26.7 ± 7.2
16.7 ± 1.2
13.3 ± 3.5
29.7 ± 5.9
  • N.S., no significant difference.

  • a Percentage parent pyrethroid metabolized during a 10-min incubation; mean ± S.D., n = 3.

  • b The percentage metabolism of pyrethroids by rat P450s was assessed by a one-sample t test. Values that were not significantly different from 0 were labeled N.S. (p < 0.05).